share_log

HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Raises Price Target to $6

HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Raises Price Target to $6

HC Wainwright & Co. 维持对Cognition Therapeutics的买入评级,提升目标价至6美元。
Benzinga ·  2024/12/19 07:27  · 评级/大行评级

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics (NASDAQ:CGTX) with a Buy and raises the price target from $5 to $6.

HC Wainwright & Co. 分析师Raghuram Selvaraju维持对Cognition Therapeutics(纳斯达克:CGTX)的买入评级,并将目标价从5美元上调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发